GlassScriptPhysician profile
Barry L Huey
NPI 1780636381
$1,686.84
in general payments reported to CMS, 2019-2025
21 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $57.50 · 2021: $323 · 2022: $120 · 2023: $484 · 2024: $127 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $312.70 | 2019-2024 | Pressurewire, Xience Skypoint, Ultreon |
| Cms Imaging, INC. | $223.33 | 2021 | |
| Novartis Pharmaceuticals Corporation | $193.12 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $170.92 | 2022-2025 | Eliquis, Camzyos |
| Abiomed | $131.42 | 2023-2024 | Impella |
| Pfizer INC. | $118.28 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $107.31 | 2021-2022 | |
| Boston Scientific Corporation | $101.13 | 2019-2025 | Watchman Flx |
| Atricure, INC. | $53.04 | 2023 | |
| Edwards Lifesciences Corporation | $40.40 | 2020-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Merck Sharp & Dohme LLC | $40.21 | 2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.49 | 2022-2023 | Lifevest |
| Heartflow, INC. | $29.21 | 2025 | |
| Daiichi Sankyo INC. | $25.28 | 2023 | Injectafer |
| Philips North America LLC | $22.26 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $19.82 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $18.49 | 2023 | Arcalyst |
| Nuwellis, INC. | $13.82 | 2019 | |
| Amgen INC. | $13.38 | 2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $11.12 | 2019 | |
| Cardiovascular Systems INC. | $10.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Huey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.